Moderna, Inc. MRNA
Loading live quote…
$49.64
+3.65
(+7.94%)
Price Chart
About Moderna, Inc.
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic…
Recent Quarters
| Quarter | Revenue | Net Income | EPS (dil.) | Gross Margin |
|---|---|---|---|---|
| 2026 Q1 | — | $-1,343,000,000 | -3.40 | -145.5% |
| 2025 Q4 | — | $-826,000,000 | -2.11 | 33.1% |
| 2025 Q3 | — | $-200,000,000 | -0.51 | 79.3% |
| 2025 Q2 | — | $-825,000,000 | -2.13 | 13.1% |
MRNA — Latest Coverage

